Ingredient 03 · Recombinant peptide

EGF (sh-Oligopeptide-1)

Epidermal growth factor is a peptide naturally present in the body. Its discovery reshaped the understanding of skin growth and aging, and earned the 1986 Nobel Prize in Physiology or Medicine.

INCI name
sh-Oligopeptide-1 (formerly Human Oligopeptide-1)
Structure
53 amino acids, ≈ 6 kDa, 3 disulfide bonds (Cys6–Cys20, Cys14–Cys31, Cys33–Cys42)
Production
Recombinant, produced by microorganisms; safety-assessed as a cosmetic ingredient
Key evidence
Cohen S, J Biol Chem 1962;237:1555-62 / 1986 Nobel Prize

Discovery

Portrait of Dr. Stanley Cohen
Dr. Stanley Cohen (1922–2020)
Ribbon model of the three-dimensional structure of EGF with disulfide bonds
3D structure of EGF

In 1962, Dr. Stanley Cohen of the United States discovered that injecting newborn mice with an extract of mouse submandibular glands caused their eyes to open early and their teeth to erupt sooner. He subsequently isolated and characterized the substance, showed that it potently stimulates the growth of cells in a variety of epithelial tissues, and named it “epidermal growth factor (EGF)” (Cohen S, J Biol Chem 1962;237:1555-62).

For this work, Dr. Cohen shared the 1986 Nobel Prize in Physiology or Medicine with Dr. Rita Levi-Montalcini. The discovery marked a major turning point in understanding skin growth, maturation, and aging, as well as the physiological changes of the skin.

Background science

How EGF works in cell biology

EGF binds the EGF receptor (EGFR) on the cell surface and activates its tyrosine kinase. In cell studies this triggers a cascade of changes, including increased intracellular calcium, glycolysis and protein synthesis, and the expression of many genes, ultimately leading to DNA synthesis and cell proliferation.

EGF receptor signaling: ERK, PI3 kinase/AKT and JAK/STAT pathways
Fig. 1EGF receptor signaling studied in cell biology: ERK, PI3 kinase/AKT and JAK/STAT pathways.

EGF is found in blood, sweat and saliva, and its levels decline with age. In cell studies it also increases the synthesis of hyaluronic acid and glycoproteins involved in hydration.

In cosmetics

A skin-conditioning peptide

EGF was originally developed as a pharmaceutical. At the much lower levels used in skincare it serves as a skin-conditioning ingredient and is used in cosmetics in Korea, Japan and elsewhere. All commercial EGF is a recombinant protein produced in microorganisms. It is listed in the PCPC International Cosmetic Ingredient Dictionary & Handbook as sh-Oligopeptide-1.

Line chart of wound area over days, control versus EGF treated
Fig. 2Change in wound area (%) over time: control vs EGF-treated. Background research data on the ingredient; this does not represent the effect of a finished cosmetic product, and StemCello products are not intended for wound care.
  • Smoother, more supple feel: Helps skin feel smoother and more supple. As a skin-conditioning ingredient, it helps soften rough, dry areas so the skin surface feels more even and pliable.
  • Hydration: Helps skin look and feel hydrated. It helps the skin hold on to moisture, leaving it with a plump, comfortable feel throughout the day.
  • Fresher-looking complexion: Supports a clearer, fresher-looking complexion as part of a daily routine. With regular use, dull and tired-looking skin appears brighter and more refreshed, and it pairs well with other conditioning ingredients.